Earn points on every order · Free shipping on orders over $159 · New products in stock
← Back to Compound Library
Tissue Repair and Recovery

LL-37

Your body’s own antimicrobial peptide (a cathelicidin). It kills bacteria, including biofilms that resist antibiotics, and supports wound healing. Used in research for stubborn infections and chronic wounds.

Research referenceCommunity compiled
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Your body’s own antimicrobial peptide (a cathelicidin).

It kills bacteria, including biofilms that resist antibiotics, and supports wound healing.

Used in research for stubborn infections and chronic wounds.

What It Does

LL-37 is the active fragment of human cathelicidin.

It disrupts bacterial membranes and biofilms, neutralizes endotoxin, and modulates immune/wound-healing responses (angiogenesis, re-epithelialization).

Because it also activates dendritic cells, it can aggravate autoimmune/inflammatory conditions; a key caution.

Reconstitution

Vial SizeBAC Water / SolventConcentration
5 mg+ 2.5 mL2 mg/mL
Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Calculated concentration—Enter both values above.
Optional conversion

Enter a target amount you already have and select the syringe capacity.

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

PhaseFrequencyAmountNotes
Weeks 1–41–3×/week (or daily AM)100–200 mcgSubQ, AM. Start low; injection-site reactions are common (mild inflammatory action).
Off2–4 weeks–Cycle to limit immune over-stimulation.
Cycle & Timing

4–6 weeks on / 2–4 weeks off.

Timing

morning SubQ; can be used locally near a wound/infection site under guidance. Caution: avoid systemic use if you have an autoimmune or chronic inflammatory condition.

Population Considerations

Unisex antimicrobial peptide, same protocol for men and women, no cycle effect. Research-stage; avoid in pregnancy.

Handling & Stacking

Injection site
SubQ, abdomen, or local to the target area. Rotate.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted: 36–46°F.
  • Best used within ~2–4 weeks, kept cold (structure-based estimate, no published data); that is close to the 28- day sterility limit, so use whichever comes first.
Side effects
Injection-site redness/itching/swelling (mild inflammatory property), possible flare of inflammatory conditions.
What to expect
  • Support for stubborn/biofilm infections and chronic wound healing in research settings.
  • Not a replacement for prescribed antibiotics when those are indicated.
  • Supply math 5mg → 1–2 vials (6-wk @ 200 mcg × 3/wk)
Pairs well with
BPC-157 / TB-500 (wound healing); KPV (anti-inflammatory); GHK-Cu (tissue repair)
Avoid
Autoimmune / chronic inflammatory disease (systemic use). Psoriasis, lupus, IBD flares. Pregnancy

Safety & Patient Education

Contraindications
Active autoimmune or chronic inflammatory disease (systemic use), can worsen it Pregnancy and lactation Hypersensitivity to the peptide
Warnings
Activates dendritic cells, may aggravate psoriasis, lupus, rosacea, IBD Injection-site inflammation is common Not a substitute for indicated antibiotics in serious infection Limited human clinical data for self-administration
Drug interactions
Immunosuppressants/biologics: opposing immune effects, coordinate with a clinician No well-characterized small-molecule interactions
Labs
Inflammatory markers (hsCRP) if used for an inflammatory indication Monitor any autoimmune condition closely
Stop criteria
Flare of an autoimmune/inflammatory condition Severe or persistent injection-site reaction Signs of worsening or systemic infection (seek medical care)
Patient education
Powerful antimicrobial, but it stimulates the immune system; not for autoimmune sufferers systemically Doesn’t replace antibiotics when those are needed for a real infection Expect some injection-site reaction; start low Stop for any autoimmune flare
References
researchdosing · peptidedosages · PubMed · thepeptidereport